Adaptive Biotechnologies (ADPT) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $26.71 +3.53%
EPS Growth %: -250.0%
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
COHR, ATS, SICP, More
EPS Growth %: -250.0%
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q1 EPS of ($0.44), $0.01 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $38.6 million versus the consensus estimate of $37.71 million.
GUIDANCE:
Adaptive Biotechnologies sees FY2022 revenue of $185-195 million, versus the consensus of $189.4 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chime Financial, Inc. (CHYM) Tops Q3 EPS by 13c ; Offers Guidance
- Mueller Water Products, Inc. (MWA) Reports In-Line Q4 EPS; Offers Guidance
- biote Corp. (BTMD) Misses Q3 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
